Supplementary Figure from Adenosine A2a Receptor Antagonism Restores Additive Cytotoxicity by Cytotoxic T Cells in Metabolically Perturbed Tumors Article Swipe
Jeroen Slaats
,
Esther Wagena
,
Daan Smits
,
Annemarie A. Berends
,
Ella Peters
,
Gert‐Jan Bakker
,
Merijn van Erp
,
Bettina Weigelin
,
Gosse J. Adema
,
Peter Friedl
·
YOU?
·
· 2023
· Open Access
·
· DOI: https://doi.org/10.1158/2326-6066.22545882
YOU?
·
· 2023
· Open Access
·
· DOI: https://doi.org/10.1158/2326-6066.22545882
Supplementary Figure from Adenosine A2a Receptor Antagonism Restores Additive Cytotoxicity by Cytotoxic T Cells in Metabolically Perturbed Tumors
Related Topics
Concepts
Metadata
- Type
- preprint
- Language
- en
- Landing Page
- https://doi.org/10.1158/2326-6066.22545882
- OA Status
- gold
- Related Works
- 10
- OpenAlex ID
- https://openalex.org/W4362548440
All OpenAlex metadata
Raw OpenAlex JSON
- OpenAlex ID
-
https://openalex.org/W4362548440Canonical identifier for this work in OpenAlex
- DOI
-
https://doi.org/10.1158/2326-6066.22545882Digital Object Identifier
- Title
-
Supplementary Figure from Adenosine A2a Receptor Antagonism Restores Additive Cytotoxicity by Cytotoxic T Cells in Metabolically Perturbed TumorsWork title
- Type
-
preprintOpenAlex work type
- Language
-
enPrimary language
- Publication year
-
2023Year of publication
- Publication date
-
2023-04-04Full publication date if available
- Authors
-
Jeroen Slaats, Esther Wagena, Daan Smits, Annemarie A. Berends, Ella Peters, Gert‐Jan Bakker, Merijn van Erp, Bettina Weigelin, Gosse J. Adema, Peter FriedlList of authors in order
- Landing page
-
https://doi.org/10.1158/2326-6066.22545882Publisher landing page
- Open access
-
YesWhether a free full text is available
- OA status
-
goldOpen access status per OpenAlex
- OA URL
-
https://doi.org/10.1158/2326-6066.22545882Direct OA link when available
- Concepts
-
Antagonism, Cytotoxicity, Cytotoxic T cell, Adenosine, Cancer research, Adenosine receptor, Chemistry, Receptor, Pharmacology, Biology, Cell biology, Biochemistry, In vitro, AgonistTop concepts (fields/topics) attached by OpenAlex
- Cited by
-
0Total citation count in OpenAlex
- Related works (count)
-
10Other works algorithmically related by OpenAlex
Full payload
| id | https://openalex.org/W4362548440 |
|---|---|
| doi | https://doi.org/10.1158/2326-6066.22545882 |
| ids.doi | https://doi.org/10.1158/2326-6066.22545882 |
| ids.openalex | https://openalex.org/W4362548440 |
| fwci | 0.0 |
| type | preprint |
| title | Supplementary Figure from Adenosine A2a Receptor Antagonism Restores Additive Cytotoxicity by Cytotoxic T Cells in Metabolically Perturbed Tumors |
| biblio.issue | |
| biblio.volume | |
| biblio.last_page | |
| biblio.first_page | |
| topics[0].id | https://openalex.org/T11193 |
| topics[0].field.id | https://openalex.org/fields/13 |
| topics[0].field.display_name | Biochemistry, Genetics and Molecular Biology |
| topics[0].score | 0.9995999932289124 |
| topics[0].domain.id | https://openalex.org/domains/1 |
| topics[0].domain.display_name | Life Sciences |
| topics[0].subfield.id | https://openalex.org/subfields/1314 |
| topics[0].subfield.display_name | Physiology |
| topics[0].display_name | Adenosine and Purinergic Signaling |
| topics[1].id | https://openalex.org/T11491 |
| topics[1].field.id | https://openalex.org/fields/27 |
| topics[1].field.display_name | Medicine |
| topics[1].score | 0.9970999956130981 |
| topics[1].domain.id | https://openalex.org/domains/4 |
| topics[1].domain.display_name | Health Sciences |
| topics[1].subfield.id | https://openalex.org/subfields/2730 |
| topics[1].subfield.display_name | Oncology |
| topics[1].display_name | CAR-T cell therapy research |
| topics[2].id | https://openalex.org/T10158 |
| topics[2].field.id | https://openalex.org/fields/27 |
| topics[2].field.display_name | Medicine |
| topics[2].score | 0.9940000176429749 |
| topics[2].domain.id | https://openalex.org/domains/4 |
| topics[2].domain.display_name | Health Sciences |
| topics[2].subfield.id | https://openalex.org/subfields/2730 |
| topics[2].subfield.display_name | Oncology |
| topics[2].display_name | Cancer Immunotherapy and Biomarkers |
| is_xpac | False |
| apc_list | |
| apc_paid | |
| concepts[0].id | https://openalex.org/C2777383412 |
| concepts[0].level | 3 |
| concepts[0].score | 0.9496428966522217 |
| concepts[0].wikidata | https://www.wikidata.org/wiki/Q4770891 |
| concepts[0].display_name | Antagonism |
| concepts[1].id | https://openalex.org/C109316439 |
| concepts[1].level | 3 |
| concepts[1].score | 0.906545102596283 |
| concepts[1].wikidata | https://www.wikidata.org/wiki/Q246181 |
| concepts[1].display_name | Cytotoxicity |
| concepts[2].id | https://openalex.org/C154317977 |
| concepts[2].level | 3 |
| concepts[2].score | 0.8292545080184937 |
| concepts[2].wikidata | https://www.wikidata.org/wiki/Q376266 |
| concepts[2].display_name | Cytotoxic T cell |
| concepts[3].id | https://openalex.org/C2776991684 |
| concepts[3].level | 2 |
| concepts[3].score | 0.561385989189148 |
| concepts[3].wikidata | https://www.wikidata.org/wiki/Q190012 |
| concepts[3].display_name | Adenosine |
| concepts[4].id | https://openalex.org/C502942594 |
| concepts[4].level | 1 |
| concepts[4].score | 0.49559056758880615 |
| concepts[4].wikidata | https://www.wikidata.org/wiki/Q3421914 |
| concepts[4].display_name | Cancer research |
| concepts[5].id | https://openalex.org/C67907053 |
| concepts[5].level | 4 |
| concepts[5].score | 0.4842197895050049 |
| concepts[5].wikidata | https://www.wikidata.org/wiki/Q356147 |
| concepts[5].display_name | Adenosine receptor |
| concepts[6].id | https://openalex.org/C185592680 |
| concepts[6].level | 0 |
| concepts[6].score | 0.46877923607826233 |
| concepts[6].wikidata | https://www.wikidata.org/wiki/Q2329 |
| concepts[6].display_name | Chemistry |
| concepts[7].id | https://openalex.org/C170493617 |
| concepts[7].level | 2 |
| concepts[7].score | 0.4475477635860443 |
| concepts[7].wikidata | https://www.wikidata.org/wiki/Q208467 |
| concepts[7].display_name | Receptor |
| concepts[8].id | https://openalex.org/C98274493 |
| concepts[8].level | 1 |
| concepts[8].score | 0.4004729688167572 |
| concepts[8].wikidata | https://www.wikidata.org/wiki/Q128406 |
| concepts[8].display_name | Pharmacology |
| concepts[9].id | https://openalex.org/C86803240 |
| concepts[9].level | 0 |
| concepts[9].score | 0.3920069932937622 |
| concepts[9].wikidata | https://www.wikidata.org/wiki/Q420 |
| concepts[9].display_name | Biology |
| concepts[10].id | https://openalex.org/C95444343 |
| concepts[10].level | 1 |
| concepts[10].score | 0.35952532291412354 |
| concepts[10].wikidata | https://www.wikidata.org/wiki/Q7141 |
| concepts[10].display_name | Cell biology |
| concepts[11].id | https://openalex.org/C55493867 |
| concepts[11].level | 1 |
| concepts[11].score | 0.32974278926849365 |
| concepts[11].wikidata | https://www.wikidata.org/wiki/Q7094 |
| concepts[11].display_name | Biochemistry |
| concepts[12].id | https://openalex.org/C202751555 |
| concepts[12].level | 2 |
| concepts[12].score | 0.21053650975227356 |
| concepts[12].wikidata | https://www.wikidata.org/wiki/Q221681 |
| concepts[12].display_name | In vitro |
| concepts[13].id | https://openalex.org/C2778938600 |
| concepts[13].level | 3 |
| concepts[13].score | 0.0 |
| concepts[13].wikidata | https://www.wikidata.org/wiki/Q389934 |
| concepts[13].display_name | Agonist |
| keywords[0].id | https://openalex.org/keywords/antagonism |
| keywords[0].score | 0.9496428966522217 |
| keywords[0].display_name | Antagonism |
| keywords[1].id | https://openalex.org/keywords/cytotoxicity |
| keywords[1].score | 0.906545102596283 |
| keywords[1].display_name | Cytotoxicity |
| keywords[2].id | https://openalex.org/keywords/cytotoxic-t-cell |
| keywords[2].score | 0.8292545080184937 |
| keywords[2].display_name | Cytotoxic T cell |
| keywords[3].id | https://openalex.org/keywords/adenosine |
| keywords[3].score | 0.561385989189148 |
| keywords[3].display_name | Adenosine |
| keywords[4].id | https://openalex.org/keywords/cancer-research |
| keywords[4].score | 0.49559056758880615 |
| keywords[4].display_name | Cancer research |
| keywords[5].id | https://openalex.org/keywords/adenosine-receptor |
| keywords[5].score | 0.4842197895050049 |
| keywords[5].display_name | Adenosine receptor |
| keywords[6].id | https://openalex.org/keywords/chemistry |
| keywords[6].score | 0.46877923607826233 |
| keywords[6].display_name | Chemistry |
| keywords[7].id | https://openalex.org/keywords/receptor |
| keywords[7].score | 0.4475477635860443 |
| keywords[7].display_name | Receptor |
| keywords[8].id | https://openalex.org/keywords/pharmacology |
| keywords[8].score | 0.4004729688167572 |
| keywords[8].display_name | Pharmacology |
| keywords[9].id | https://openalex.org/keywords/biology |
| keywords[9].score | 0.3920069932937622 |
| keywords[9].display_name | Biology |
| keywords[10].id | https://openalex.org/keywords/cell-biology |
| keywords[10].score | 0.35952532291412354 |
| keywords[10].display_name | Cell biology |
| keywords[11].id | https://openalex.org/keywords/biochemistry |
| keywords[11].score | 0.32974278926849365 |
| keywords[11].display_name | Biochemistry |
| keywords[12].id | https://openalex.org/keywords/in-vitro |
| keywords[12].score | 0.21053650975227356 |
| keywords[12].display_name | In vitro |
| language | en |
| locations[0].id | doi:10.1158/2326-6066.22545882 |
| locations[0].is_oa | True |
| locations[0].source | |
| locations[0].license | cc-by |
| locations[0].pdf_url | |
| locations[0].version | acceptedVersion |
| locations[0].raw_type | posted-content |
| locations[0].license_id | https://openalex.org/licenses/cc-by |
| locations[0].is_accepted | True |
| locations[0].is_published | False |
| locations[0].raw_source_name | |
| locations[0].landing_page_url | https://doi.org/10.1158/2326-6066.22545882 |
| indexed_in | crossref |
| authorships[0].author.id | https://openalex.org/A5076370806 |
| authorships[0].author.orcid | https://orcid.org/0000-0003-3800-3138 |
| authorships[0].author.display_name | Jeroen Slaats |
| authorships[0].author_position | first |
| authorships[0].raw_author_name | Jeroen Slaats |
| authorships[0].is_corresponding | False |
| authorships[1].author.id | https://openalex.org/A5077005500 |
| authorships[1].author.orcid | |
| authorships[1].author.display_name | Esther Wagena |
| authorships[1].author_position | middle |
| authorships[1].raw_author_name | Esther Wagena |
| authorships[1].is_corresponding | False |
| authorships[2].author.id | https://openalex.org/A5083969796 |
| authorships[2].author.orcid | https://orcid.org/0000-0002-3090-4321 |
| authorships[2].author.display_name | Daan Smits |
| authorships[2].author_position | middle |
| authorships[2].raw_author_name | Daan Smits |
| authorships[2].is_corresponding | False |
| authorships[3].author.id | https://openalex.org/A5006146706 |
| authorships[3].author.orcid | https://orcid.org/0000-0001-5124-8821 |
| authorships[3].author.display_name | Annemarie A. Berends |
| authorships[3].author_position | middle |
| authorships[3].raw_author_name | Annemarie A. Berends |
| authorships[3].is_corresponding | False |
| authorships[4].author.id | https://openalex.org/A5031426836 |
| authorships[4].author.orcid | https://orcid.org/0000-0002-3622-8475 |
| authorships[4].author.display_name | Ella Peters |
| authorships[4].author_position | middle |
| authorships[4].raw_author_name | Ella Peters |
| authorships[4].is_corresponding | False |
| authorships[5].author.id | https://openalex.org/A5082642221 |
| authorships[5].author.orcid | https://orcid.org/0000-0003-3602-0014 |
| authorships[5].author.display_name | Gert‐Jan Bakker |
| authorships[5].author_position | middle |
| authorships[5].raw_author_name | Gert-Jan Bakker |
| authorships[5].is_corresponding | False |
| authorships[6].author.id | https://openalex.org/A5067213239 |
| authorships[6].author.orcid | https://orcid.org/0000-0002-9642-9789 |
| authorships[6].author.display_name | Merijn van Erp |
| authorships[6].author_position | middle |
| authorships[6].raw_author_name | Merijn van Erp |
| authorships[6].is_corresponding | False |
| authorships[7].author.id | https://openalex.org/A5019346530 |
| authorships[7].author.orcid | https://orcid.org/0000-0003-4460-3113 |
| authorships[7].author.display_name | Bettina Weigelin |
| authorships[7].author_position | middle |
| authorships[7].raw_author_name | Bettina Weigelin |
| authorships[7].is_corresponding | False |
| authorships[8].author.id | https://openalex.org/A5015323424 |
| authorships[8].author.orcid | https://orcid.org/0000-0002-6750-1665 |
| authorships[8].author.display_name | Gosse J. Adema |
| authorships[8].author_position | middle |
| authorships[8].raw_author_name | Gosse J. Adema |
| authorships[8].is_corresponding | False |
| authorships[9].author.id | https://openalex.org/A5026527299 |
| authorships[9].author.orcid | https://orcid.org/0000-0002-0119-4041 |
| authorships[9].author.display_name | Peter Friedl |
| authorships[9].author_position | last |
| authorships[9].raw_author_name | Peter Friedl |
| authorships[9].is_corresponding | False |
| has_content.pdf | False |
| has_content.grobid_xml | False |
| is_paratext | False |
| open_access.is_oa | True |
| open_access.oa_url | https://doi.org/10.1158/2326-6066.22545882 |
| open_access.oa_status | gold |
| open_access.any_repository_has_fulltext | False |
| created_date | 2025-10-10T00:00:00 |
| display_name | Supplementary Figure from Adenosine A2a Receptor Antagonism Restores Additive Cytotoxicity by Cytotoxic T Cells in Metabolically Perturbed Tumors |
| has_fulltext | False |
| is_retracted | False |
| updated_date | 2025-11-06T03:46:38.306776 |
| primary_topic.id | https://openalex.org/T11193 |
| primary_topic.field.id | https://openalex.org/fields/13 |
| primary_topic.field.display_name | Biochemistry, Genetics and Molecular Biology |
| primary_topic.score | 0.9995999932289124 |
| primary_topic.domain.id | https://openalex.org/domains/1 |
| primary_topic.domain.display_name | Life Sciences |
| primary_topic.subfield.id | https://openalex.org/subfields/1314 |
| primary_topic.subfield.display_name | Physiology |
| primary_topic.display_name | Adenosine and Purinergic Signaling |
| related_works | https://openalex.org/W3030859185, https://openalex.org/W1974998794, https://openalex.org/W2987313600, https://openalex.org/W1382943, https://openalex.org/W130088918, https://openalex.org/W2062660503, https://openalex.org/W2430034614, https://openalex.org/W2020168868, https://openalex.org/W2426680130, https://openalex.org/W1965742203 |
| cited_by_count | 0 |
| locations_count | 1 |
| best_oa_location.id | doi:10.1158/2326-6066.22545882 |
| best_oa_location.is_oa | True |
| best_oa_location.source | |
| best_oa_location.license | cc-by |
| best_oa_location.pdf_url | |
| best_oa_location.version | acceptedVersion |
| best_oa_location.raw_type | posted-content |
| best_oa_location.license_id | https://openalex.org/licenses/cc-by |
| best_oa_location.is_accepted | True |
| best_oa_location.is_published | False |
| best_oa_location.raw_source_name | |
| best_oa_location.landing_page_url | https://doi.org/10.1158/2326-6066.22545882 |
| primary_location.id | doi:10.1158/2326-6066.22545882 |
| primary_location.is_oa | True |
| primary_location.source | |
| primary_location.license | cc-by |
| primary_location.pdf_url | |
| primary_location.version | acceptedVersion |
| primary_location.raw_type | posted-content |
| primary_location.license_id | https://openalex.org/licenses/cc-by |
| primary_location.is_accepted | True |
| primary_location.is_published | False |
| primary_location.raw_source_name | |
| primary_location.landing_page_url | https://doi.org/10.1158/2326-6066.22545882 |
| publication_date | 2023-04-04 |
| publication_year | 2023 |
| referenced_works_count | 0 |
| abstract_inverted_index.T | 12 |
| abstract_inverted_index.by | 10 |
| abstract_inverted_index.in | 14 |
| abstract_inverted_index.A2a | 4 |
| abstract_inverted_index.from | 2 |
| abstract_inverted_index.Cells | 13 |
| abstract_inverted_index.Figure | 1 |
| abstract_inverted_index.Tumors | 17 |
| abstract_inverted_index.Additive | 8 |
| abstract_inverted_index.Receptor | 5 |
| abstract_inverted_index.Restores | 7 |
| abstract_inverted_index.Adenosine | 3 |
| abstract_inverted_index.Cytotoxic | 11 |
| abstract_inverted_index.Perturbed | 16 |
| abstract_inverted_index.Antagonism | 6 |
| abstract_inverted_index.Cytotoxicity | 9 |
| abstract_inverted_index.Metabolically | 15 |
| abstract_inverted_index.Supplementary | 0 |
| cited_by_percentile_year | |
| countries_distinct_count | 0 |
| institutions_distinct_count | 10 |
| citation_normalized_percentile.value | 0.14643249 |
| citation_normalized_percentile.is_in_top_1_percent | False |
| citation_normalized_percentile.is_in_top_10_percent | False |